Septic Arthritis: Background, Etiology and Pathophysiology, Prognosis
- ️Invalid Date
Background
The term Septic Arthritis (SA) represents an invasion of a joint space by a variety of microorganisms, most commonly bacteria. Various types of viruses, mycobacteria, and fungi also may be involved. This discussion will focus primarily on the bacterial pathogens. Despite timely institution of appropriate treatment, SA continues to produce significant rates of morbidity and mortality. Reactive arthritis represents a sterile inflammatory process that may be triggered by an extra-articular infection.
Approximately 20,000 cases of SA occur in the United States each year (7.8 cases per 100,000 person-years), with a similar incidence occurring in Europe. [1] The incidence of SA-caused disseminated gonococcal infection is 2.8 cases per 100,000 person-years.
By 2030, an estimated 4 million hip and knee arthroplasties will be performed per year in the United States. [2] The incidence of prosthetic joint infection (PJI) among all prosthesis recipients ranges from 2% to 10%. Since postoperative surveillance is limited to the operative hospital, it may result in significant underestimation of the rate of PJIs. [3, 4] It is important to remember that any patients who have undergone treatment for infection of a native joint are at a lifetime risk for PJI after a total joint arthroplasty of that particular joint. [5]
PJIs are classified according to the onset of symptoms following implantation of the joint:
Early PJI symptoms occur within 30 days of implantation.
Late acute PJI symptoms begin more than 30 days after implantation of the device. It is the most frequent type of PJI, and symptoms are present 7 days or fewer prior to diagnosis. There is no evidence of sinus tracts. [4]
The duration of symptoms in patients with late indeterminate PJI is between 8 and 30 days. There is no evidence of sinus tracts.
Late chronic PJI occurs more than 30 days after placement, with symptoms of greater than 30 days or the presence of a sinus tract.
Septic arthritis is increasingly common among persons older than 65 years, among immunosuppressed individuals, and among those with various comorbidities such as diabetes. Fifty-six percent of patients with septic arthritis are male.
Gonococcal and nongonococcal bacterial/suppurative arthritis
Bacterial SA is commonly described as either gonococcal or nongonococcal. [1, 2, 6, 7, 8, 9] Neisseria gonorrhoeae remains the most common pathogen (75% of cases) among younger sexually active individuals. [10, 11, 12] The increased incidence of S aureus parallels the rise of prosthetic joint implantation, intravenous drug abuse (IVDA), and the use of immunosuppressive agents. This pathogen causes 80% of infected joints affected by rheumatoid arthritis (RA).
Streptococcal species, such as Streptococcus viridans, S pneumoniae, [13, 14] and group B streptococci [15] account for 20% of cases. Aerobic gram-negative rods are involved in 20-25% of cases. Most of these infections occur among the very young and very old, [16] patients with diabetes, immunosuppressed individuals, and people who use intravenous drugs. [17, 18]
Infection of the cartilaginous joints (sternoclavicular, sacroiliac, and pubic joints) with Pseudomonas aeruginosa or Serratia species occurs almost exclusively among people who abuse intravenous drugs. Individuals with leukemia are susceptible to Aeromonas infections. [19]
Polymicrobial joint infections (5-10% of cases) and infection with anaerobic organisms (5% of cases) are usually a consequence of trauma or abdominal infection. Individuals with multiple pathogens have a higher rate of previous native and prosthetic joint infections. The most common pathogens were coagulase-negative Staphylococcus (CoNS), MSSA, and enterococci. [5]
The pathogen of Lyme disease, Borrelia burgdorferi, commonly produces a septic arthritis picture. [18] Occasionally, the signs and symptoms of the acute infection persist despite successful eradication of this pathogen. This appears to result from ongoing synovial inflammation due to persistent vascular damage, and autoimmune processes that interfere with appropriate tissue healing.
Brucella may cause septic arthritis in areas where cattle are not vaccinated. The organism of Whipple disease, Mycoplasma species, and Ureaplasma species infrequently involve septic joints. [2]
A wide variety of viruses (eg, human immunodeficiency virus [HIV], lymphocytic choriomeningitis virus, hepatitis B virus, rubella virus), mycobacteria, fungi (eg, Histoplasma species, Sporothrix schenckii, Coccidioides immitis, Blastomyces species), and other pathogens produce nonsuppurative joint infections. [19]
Types of prosthetic joint infections
There are three major categories of PJIs: those that develop within 3 months of implantation; those that appear within 3 to 24 months of implantation; and those that occur later than 24 months. Most cases of early prosthetic joint infection are caused by S aureus. The 3- to 24-month group usually are caused by coagulase-negative S aureus (CoNS) or gram-negative aerobes, both of which are acquired in the operating room. Late cases of prosthetic joint infection usually are the result of hematogenous spread from a variety of infectious foci. [20, 21] Unusually, they may arise from a dormant infection of periprosthetic tissue.
Reactive arthritis represents a sterile inflammatory process that is triggered by a variety of extra-articular infections. [22]
See also Pediatric Septic Arthritis, Pediatric Septic Arthritis Surgery, and Septic Arthritis Surgery.
Etiology and Pathophysiology
Organisms may invade the joint by direct inoculation, by contiguous spread from infected periarticular tissue, or most commonly, via the bloodstream. [9]
The normal joint has several protective components. Healthy synovial cells possess significant phagocytic activity, and synovial fluid normally posseses significant bactericidal activity. Rheumatoid arthritis and systemic lupus erythematosus hamper the defensive functions of synovial fluid and decrease chemotaxis and phagocytic function of polymorphonuclear leukocytes. Patients with deficiencies of the terminal components of complement are susceptible to both Neisserial bacteremia and joint infections.
Pathogenic invasion
Previously damaged joints, especially those damaged by rheumatoid arthritis, are the most susceptible to infection. The synovial membranes of these joints exhibit neovascularization and increased adhesion factors; both conditions increase the chance of bacteremia, resulting in joint infection. Some microorganisms have properties that promote their tropism to the synovium. S aureus readily binds to articular sialoprotein, fibronectin, collagen, elastin, hyaluronic acid, and prosthetic material via specific tissue adhesion factors (microbial surface components recognizing adhesive matrix molecules [MSCRAMMs]). In adults, the arteriolar anastomosis between the epiphysis and the synovium permits the spread of osteomyelitis into the joint space.
The major consequence of bacterial invasion is damage to articular cartilage. This may be due to the particular organism's pathologic properties, such as the chondrocyte proteases of S aureus, as well as to the host's polymorphonuclear leukocytes response. The cells stimulate synthesis of cytokines and other inflammatory products, resulting in the hydrolysis of essential collagen and proteoglycans. Infection with N gonorrhoeae induces a relatively mild influx of white blood cells (WBCs) into the joint, explaining, in part, the minimal joint destruction observed in cases of infection with this organism relative to destruction associated with S aureus infection.
As the destructive process continues, pannus formation begins, and cartilage erosion occurs at the lateral margins of the joint. Large effusions, which can occur in infections of the hip joint, impair the blood supply and result in aseptic necrosis of bone. These destructive processes are well advanced as early as 3 days into the course of untreated infection.
Viral infections may cause direct invasion (rubella) or production of antigen/antibody complexes. Such immunologic mechanisms occur in infections with hepatitis B, parvovirus B19, and lymphocytic choriomeningitis viruses.
Reactive/postexposure process
Reactive, or postexposure, arthritis is observed more commonly in patients with human lymphocyte antigen B27 (HLA-B27) histocompatibility antigens. Although various infections can cause reactive arthritis, gastrointestinal processes are by far the most common. Gastrointestinal pathogens associated with reactive arthritis include the following [22] :
-
Salmonella enteritidis
-
Salmonella typhimurium
-
Yersinia enterocolitica
-
Campylobacter jejuni
-
Clostridium difficile
-
Shigella sonnei
-
Entamoeba histolytica
-
Cryptosporidium
Genitourinary infections, especially those due to Chlamydia trachomatis, are the second most common cause of reactive arthritis. The arthritis of Lyme disease usually results from immunologic mechanisms, with a minority of cases due to direct invasion by an organism. A reactive/postexposure process may occur months after the gastrointestinal or genitourinary process has resolved.
COVID-19 infection has been increasingly implicated as a cause of reactive arthritis especially among patients with rheumatoid arthritis. [1, 23]
PJIs
PJIs may be a consequence of local infection, such as superficial surgical site infections/delayed wound healing (60-80% of cases). [4] Twenty to forty percent are due to continuous or transient bacteremias. [2] These may be spontaneous (ie, gingival disease) or secondary to various surgical manipulations. Delayed wound healing is a major factor behind early prosthetic joint infection. This increased risk resolves with the eventual development of a surrounding pseudocapsule, which significantly lessens the infectious risk posed by bloodstream infections.
Recommendations for the use of postoperative prophylactic antibiotics for revisions of total joint arthroplasties have yet to be established. [4]
The biofilm of coagulase-negative S aureus (CoNS) protects the pathogen from the host's defenses, as well as from various antibiotics. Polymethylmethacrylate cement inhibits WBC and complement function.
Overall, the most common organisms of prosthetic joint infections are CoNS (22% of cases) and S aureus (22% of cases). Enteric gram-negative organisms account for 25% of isolates. [21] Streptococci, including S viridans, enterococci, and the beta-hemolytic streptococci, cause 21% of cases. Anaerobes are isolated from 10% of patients.
Other distinctive host and/or situation-pathogen associations have been described, including Pasteurella multocida, Capnocytophaga species (dog and cat bites), Eikenella corrodens, anaerobes (especially Fusobacterium nucleatum and streptococcal species [human bites]), Aeromonas hydrophila (myelogenous leukemia), P aeruginosa, Serratia species, Candida species (particularly common in persons who abuse intravenous drugs), Mycobacterium marinum (water exposure), S schenckii (gardening), and S pneumoniae (sickle cell anemia).
Unlike their causative role in sickle cell osteomyelitis, Salmonella species are not associated with the septic arthritis of sickle cell anemia. Ten percent to 30% of patients with brucellosis have lumbosacral spine involvement.
Prognosis
The chief morbidity of septic arthritis is significant dysfunction of the joint, even if treated properly. Fifty percent of adults with septic arthritis have significant sequelae of decreased range of motion or chronic pain after infection. [1] Thirty percent of reactive arthritis cases may become chronic. Complications include dysfunctional joints, osteomyelitis, and sepsis.
Predictors of poor outcome in suppurative arthritis include the following [24] :
-
Age older than 60 years
-
Infection of the hip or shoulder joints
-
Underlying rheumatoid arthritis
-
Positive findings on synovial fluid cultures after 7 days of appropriate therapy
-
Delay of 7 days or longer in instituting therapy
The mortality rate primarily depends on the causative organism. N gonorrhoeae septic arthritis carries an extremely low mortality rate, whereas that of S aureus can approach 50%. [23] S aureus is the most common cause of septic arthritis in all age groups. Among those aged 15 to 50 years, N gonorrhea runs a close second, especially among those who are sexually active.
Roerdink RL, Huijbregts HJTAM, van Lieshout AWT, Dietvorst M, van der Zwaard BC. The difference between native septic arthritis and prosthetic joint infections: A review of literature. J Orthop Surg (Hong Kong). 2019 May-Aug. 27 (2):2309499019860468. [QxMD MEDLINE Link].
Ross JJ. Septic Arthritis of Native Joints. Infect Dis Clin North Am. 2017 Jun. 31 (2):203-218. [QxMD MEDLINE Link].
Yokoe DS, Avery TR, Platt R, Huang SS. Reporting surgical site infections following total hip and knee arthroplasty: impact of limiting surveillance to the operative hospital. Clin Infect Dis. 2013 Nov. 57(9):1282-8. [QxMD MEDLINE Link].
Eriksson HK, Lazarinis S. Patient-related factors associated with superficial surgical site infection and progression to a periprosthetic joint infection after elective primary total joint arthroplasty: a single-centre, retrospective study in Sweden. BMJ Open. 2022 Sep 19. 12 (9):e060754. [QxMD MEDLINE Link].
Futterman O, Lieber SB, Nasrullah K, Fowler ML, Shmerling RH, Paz Z. Clinical characteristics of patients with polymicrobial septic arthritis. Eur J Clin Microbiol Infect Dis. 2019 Jul. 38 (7):1327-1332. [QxMD MEDLINE Link].
Del Pozo JL, Patel R. Clinical practice. Infection associated with prosthetic joints. N Engl J Med. 2009 Aug 20. 361(8):787-94. [QxMD MEDLINE Link]. [Full Text].
Berbari EF, Marculescu C, Sia I, Lahr BD, Hanssen AD, Steckelberg JM, et al. Culture-negative prosthetic joint infection. Clin Infect Dis. 2007 Nov 1. 45(9):1113-9. [QxMD MEDLINE Link].
Cucurull E, Espinoza LR. Gonococcal arthritis. Rheum Dis Clin North Am. 1998 May. 24 (2):305-22. [QxMD MEDLINE Link].
Rice PA. Gonococcal arthritis (disseminated gonococcal infection). Infect Dis Clin North Am. 2005 Dec. 19 (4):853-61. [QxMD MEDLINE Link].
Broy SB, Schmid FR. A comparison of medical drainage (needle aspiration) and surgical drainage (arthrotomy or arthroscopy) in the initial treatment of infected joints. Clin Rheum Dis. 1986 Aug. 12 (2):501-22. [QxMD MEDLINE Link].
McGuire NM, Kauffman CA. Septic arthritis in the elderly. J Am Geriatr Soc. 1985 Mar. 33 (3):170-4. [QxMD MEDLINE Link].
Smith JW, Piercy EA. Infectious arthritis. Clin Infect Dis. 1995 Feb. 20 (2):225-30; quiz 231. [QxMD MEDLINE Link].
Baraboutis I, Skoutelis A. Streptococcus pneumoniae septic arthritis in adults. Clin Microbiol Infect. 2004 Dec. 10(12):1037-9. [QxMD MEDLINE Link].
Raad J, Peacock JE Jr. Septic arthritis in the adult caused by Streptococcus pneumoniae: a report of 4 cases and review of the literature. Semin Arthritis Rheum. 2004 Oct. 34(2):559-69. [QxMD MEDLINE Link].
Corvec S, Illiaquer M, Touchais S, et al. Clinical features of group B Streptococcus prosthetic joint infections and molecular characterization of isolates. J Clin Microbiol. 2011 Jan. 49(1):380-2. [QxMD MEDLINE Link]. [Full Text].
Margaretten ME, Kohlwes J, Moore D, Bent S. Does this adult patient have septic arthritis?. JAMA. 2007 Apr 4. 297(13):1478-88. [QxMD MEDLINE Link].
Ross JJ, Shamsuddin H. Sternoclavicular septic arthritis: review of 180 cases. Medicine (Baltimore). 2004 May. 83 (3):139-48. [QxMD MEDLINE Link].
Lochhead RB, Strle K, Arvikar SL, Weis JJ, Steere AC. Lyme arthritis: linking infection, inflammation and autoimmunity. Nat Rev Rheumatol. 2021 Aug. 17 (8):449-461. [QxMD MEDLINE Link].
Spinicci M, Corti G. Septic arthritis in the antimicrobial stewardship era. Intern Emerg Med. 2020 Jun. 15 (4):567-569. [QxMD MEDLINE Link].
Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004 Oct 14. 351(16):1645-54. [QxMD MEDLINE Link].
Hsieh PH, Lee MS, Hsu KY, Chang YH, Shih HN, Ueng SW. Gram-negative prosthetic joint infections: risk factors and outcome of treatment. Clin Infect Dis. 2009 Oct 1. 49(7):1036-43. [QxMD MEDLINE Link].
Hannu T. Reactive arthritis. Best Pract Res Clin Rheumatol. 2011 Jun. 25 (3):347-57. [QxMD MEDLINE Link].
Malek Mahdavi A, Varshochi M, Hajialilo M, Dastgiri S, Khabbazi R, Khabbazi A. Factors associated with COVID-19 and its outcome in patients with rheumatoid arthritis. Clin Rheumatol. 2021 Jun 29. 40(5):884-92. [QxMD MEDLINE Link].
Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, et al. Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013 Jan. 56 (1):1-10. [QxMD MEDLINE Link].
Kaandorp CJ, Dinant HJ, van de Laar MA, et al. Incidence and sources of native and prosthetic joint infection: a community based prospective survey. Ann Rheum Dis. 1997 Aug. 56(8):470-5. [QxMD MEDLINE Link].
Nair R, Schweizer ML, Singh N. Septic Arthritis and Prosthetic Joint Infections in Older Adults. Infect Dis Clin North Am. 2017 Dec. 31 (4):715-729. [QxMD MEDLINE Link].
Colston J, Atkins B. Bone and joint infection. Clin Med (Lond). 2018 Mar. 18 (2):150-154. [QxMD MEDLINE Link].
Zimmermann B 3rd, Mikolich DJ, Ho G Jr. Septic bursitis. Semin Arthritis Rheum. 1995 Jun. 24(6):391-410. [QxMD MEDLINE Link].
Goldenberg DL. Septic arthritis and other infections of rheumatological significance. Rheum Clin NA. 1991. 17:149. [QxMD MEDLINE Link].
Cunha CB, Cunha BA. Infectious Diseases and Antimicrobial Stewardship in Critical Care Medicine. 4th. Boca Raton, FL: CRC Press; June 13, 2022.
Parvizi J, Tan TL, Goswami K, Higuera C, Della Valle C, Chen AF, et al. The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria. J Arthroplasty. 2018 May. 33 (5):1309-1314.e2. [QxMD MEDLINE Link].
Chouk M, Verhoeven F, Sondag M, Guillot X, Prati C, Wendling D. Value of serum procalcitonin for the diagnosis of bacterial septic arthritis in daily practice in rheumatology. Clin Rheumatol. 2019 Aug. 38 (8):2265-2273. [QxMD MEDLINE Link].
Garcia-De La Torre I. Advances in the management of septic arthritis. Rheum Dis Clin North Am. 2003 Feb. 29(1):61-75. [QxMD MEDLINE Link].
Wilson ML, Winn W. Laboratory diagnosis of bone, joint, soft-tissue, and skin infections. Clin Infect Dis. 2008 Feb 1. 46(3):453-7. [QxMD MEDLINE Link].
Sebastian S, Malhotra R, Sreenivas V, Kapil A, Chaudhry R, Dhawan B. Sonication of orthopaedic implants: A valuable technique for diagnosis of prosthetic joint infections. J Microbiol Methods. 2018 Mar. 146:51-54. [QxMD MEDLINE Link].
Mathews CJ, Coakley G. Septic arthritis: current diagnostic and therapeutic algorithm. Curr Opin Rheumatol. 2008 Jul. 20 (4):457-62. [QxMD MEDLINE Link].
Wise CM, Morris CR, Wasilauskas BL, et al. Gonococcal arthritis in an era of increasing penicillin resistance. Presentations and outcomes in 41 recent cases (1985-1991). Arch Intern Med. 1994 Dec 12-26. 154(23):2690-5. [QxMD MEDLINE Link].
Berlina AN, Zherdev AV, Dzantiev BB. Monitoring Antibiotics and Inflammatory Markers in Human Blood: Impact in Choice of Antibiotic Therapy and used Methods. Biomedical and Pharmacology Journal. 2020. 13(3):
Lim W, Barras CD, Zadow S. Radiologic Mimics of Osteomyelitis and Septic Arthritis: A Pictorial Essay. Radiol Res Pract. 2021. 2021:9912257. [QxMD MEDLINE Link].
Palestro CJ. FDG-PET in musculoskeletal infections. Semin Nucl Med. 2013 Sep. 43(5):367-76. [QxMD MEDLINE Link].
Li HK, Rombach I, Zambellas R, Walker AS, et al. Oral versus Intravenous Antibiotics for Bone and Joint Infection. N Engl J Med. 2019 Jan 31. 380 (5):425-436. [QxMD MEDLINE Link].
Gundavda MK, Katariya A, Reddy R, Agarwal MG. Fighting Megaprosthetic Infections: What are the Chances of Winning?. Indian J Orthop. 2020 Jul. 54 (4):469-476. [QxMD MEDLINE Link].
Walter N, Rupp M, Baertl S, Alt V. The role of multidisciplinary teams in musculoskeletal infection. Bone Joint Res. 2022 Jan. 11 (1):6-7. [QxMD MEDLINE Link].
Gjika E, Beaulieu JY, Vakalopoulos K, Gauthier M, Bouvet C, Gonzalez A, et al. Two weeks versus four weeks of antibiotic therapy after surgical drainage for native joint bacterial arthritis: a prospective, randomised, non-inferiority trial. Ann Rheum Dis. 2019 Aug. 78 (8):1114-1121. [QxMD MEDLINE Link].
Bernard L, Arvieux C, Brunschweiler B, et al. Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection. N Engl J Med. 2021 May 27. 384 (21):1991-2001. [QxMD MEDLINE Link].
Manning L, Metcalf S, Clark B, et all. Clinical Characteristics, Etiology, and Initial Management Strategy of Newly Diagnosed Periprosthetic Joint Infection: A Multicenter, Prospective Observational Cohort Study of 783 Patients. Open Forum Infect Dis. 2020 May. 7 (5):ofaa068. [QxMD MEDLINE Link].
Watkins RR, Gowen R, Lionakis MS, Ghannoum M. Update on the Pathogenesis, Virulence, and Treatment of Candida auris. Pathog Immun. 2022. 7 (2):46-65. [QxMD MEDLINE Link].
Koeppe J, Johnson S, Morroni J, Siracusa-Rick C, Armon C. Suppressive antibiotic therapy for retained infected prosthetic joints: case series and review of the literature. Infect Dis Clin Pract. 2008. 16(4):224-9. [Full Text].
Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015 Jun 5. 64 (RR-03):1-137. [QxMD MEDLINE Link].
Berbari EF, Osmon DR, Carr A, et al. Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis. 2010 Jan 1. 50(1):8-16. [QxMD MEDLINE Link].
Abram SGF, Alvand A, Judge A, Beard DJ, Price AJ. Mortality and adverse joint outcomes following septic arthritis of the native knee: a longitudinal cohort study of patients receiving arthroscopic washout. Lancet Infect Dis. 2020 Mar. 20 (3):341-349. [QxMD MEDLINE Link].
Pouderoux C, Becker A, Goutelle S, Lustig S, Triffault-Fillit C, Daoud F, et al. Subcutaneous suppressive antibiotic therapy for bone and joint infections: safety and outcome in a cohort of 10 patients. J Antimicrob Chemother. 2019 Jul 1. 74 (7):2060-2064. [QxMD MEDLINE Link].
Cunha BA, Hage JE, Cunha CB, et al. Empiric therapy based on clinical syndrome. Cunha CB, Cunha BA. Antibiotic Essentials. 17. New Deli London: Jaycee Brothers Medical publishers; 2020. 17: 134-139.
Renz N, Trampuz A, Zimmerli W. Controversy about the Role of Rifampin in Biofilm Infections: Is It Justified?. Antibiotics (Basel). 2021 Feb 5. 10 (2):[QxMD MEDLINE Link].
Tonnelier M, Bouras A, Joseph C, Samad YE, Brunschweiler B, Schmit JL, et al. Impact of rifampicin dose in bone and joint prosthetic device infections due to Staphylococcus spp: a retrospective single-center study in France. BMC Infect Dis. 2021 Feb 12. 21 (1):174. [QxMD MEDLINE Link].
Cunha CB, Cunha BA. Antibiotic pearls and pitfalls. Cunha CB, Hage JE, Cunha BA. Antibiotic Essentials. 17. New Delhi, London: JayPee Medical Publishers; 2020. 17: 525-538.
Ribeiro TC, Honda EK, Daniachi D, Cury RPL, da Silva CB, Klautau GB, et al. The impact of sonication cultures when the diagnosis of prosthetic joint infection is inconclusive. PLoS One. 2021. 16 (7):e0252322. [QxMD MEDLINE Link].
Yakkanti RR, Vanden Berge D, Summers SH, Mansour KL, Lavin AC, Hernandez VH. Extended Postoperative Prophylactic Antibiotics for Primary and Aseptic Revision Total Joint Arthroplasty: A Systematic Review. J Am Acad Orthop Surg. 2022 Jun 1. 30 (11):e822-e832. [QxMD MEDLINE Link].
Author
Specialty Editor Board
Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference
Disclosure: Received salary from Medscape for employment. for: Medscape.
Aaron E Glatt, MD, MACP, FIDSA, FSHEA Chairman, Department of Medicine, Chief, Division of Infectious Diseases, Hospital Epidemiologist, Mount Sinai South Nassau; Professor of Medicine, Icahn School of Medicine at Mount Sinai
Aaron E Glatt, MD, MACP, FIDSA, FSHEA is a member of the following medical societies: American Association for Physician Leadership, American College of Chest Physicians, American College of Physicians, American College of Physicians-American Society of Internal Medicine, American Medical Association, American Society for Microbiology, American Thoracic Society, American Venereal Disease Association, Infectious Diseases Society of America, International AIDS Society, Society for Healthcare Epidemiology of America
Disclosure: Nothing to disclose.
Chief Editor
Michael Stuart Bronze, MD David Ross Boyd Professor and Chairman, Department of Medicine, Stewart G Wolf Endowed Chair in Internal Medicine, Department of Medicine, University of Oklahoma Health Science Center; Master of the American College of Physicians; Fellow, Infectious Diseases Society of America; Fellow of the Royal College of Physicians, London
Michael Stuart Bronze, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, American Medical Association, Association of Professors of Medicine, Infectious Diseases Society of America, Oklahoma State Medical Association, Southern Society for Clinical Investigation
Disclosure: Nothing to disclose.
Additional Contributors
Maria D Mileno, MD Associate Professor of Medicine, Division of Infectious Diseases, The Warren Alpert Medical School of Brown University
Maria D Mileno, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, International Society of Travel Medicine, Sigma Xi, The Scientific Research Honor Society
Disclosure: Nothing to disclose.